Dr Reddy’s Q4 Disappoints Brokerages On Weak Quarter, Semaglutide Ramp-Up Delays — Check Targets

Brokerages broadly maintain a bearish view. Morgan Stanley cut its target price to Rs 1,215 from Rs 1,259. Citi maintained its Sell call, and Jefferies echoed the sentiment, with an Underperform rating.